Libo Chen

459 total citations
26 papers, 295 citations indexed

About

Libo Chen is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Libo Chen has authored 26 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Surgery. Recurrent topics in Libo Chen's work include Thyroid Cancer Diagnosis and Treatment (21 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Thyroid and Parathyroid Surgery (4 papers). Libo Chen is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (21 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Thyroid and Parathyroid Surgery (4 papers). Libo Chen collaborates with scholars based in China, Germany and United States. Libo Chen's co-authors include Yuchen Jin, Min Liu, Hankui Lu, Yan Shen, Ruisen Zhu, Quan‐Yong Luo, Yongli Yu, Maomei Ruan, Douglas Van Nostrand and Hao Fu and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer Letters.

In The Last Decade

Libo Chen

22 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Libo Chen China 10 216 69 58 52 49 26 295
Hans H G Verbeek Netherlands 5 195 0.9× 41 0.6× 66 1.1× 73 1.4× 36 0.7× 10 242
Carla Vaz Ferreira Brazil 8 215 1.0× 77 1.1× 65 1.1× 60 1.2× 15 0.3× 11 280
Libo Chen China 11 213 1.0× 109 1.6× 58 1.0× 58 1.1× 56 1.1× 21 299
Patricia Borges de Souza Italy 7 223 1.0× 119 1.7× 84 1.4× 36 0.7× 27 0.6× 12 367
Teresa Ramone Italy 9 297 1.4× 77 1.1× 103 1.8× 53 1.0× 27 0.6× 23 352
Fernando Jerkovich Argentina 11 193 0.9× 42 0.6× 84 1.4× 67 1.3× 25 0.5× 24 288
Adriana Gaspar da Rocha Portugal 7 258 1.2× 74 1.1× 51 0.9× 62 1.2× 45 0.9× 12 310
Ruichao Zeng China 9 233 1.1× 134 1.9× 45 0.8× 142 2.7× 27 0.6× 12 364
Tomasz Trybek Poland 11 205 0.9× 102 1.5× 57 1.0× 60 1.2× 30 0.6× 16 313
Angela Nesca Italy 10 277 1.3× 46 0.7× 55 0.9× 131 2.5× 40 0.8× 11 328

Countries citing papers authored by Libo Chen

Since Specialization
Citations

This map shows the geographic impact of Libo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Chen more than expected).

Fields of papers citing papers by Libo Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Chen. The network helps show where Libo Chen may publish in the future.

Co-authorship network of co-authors of Libo Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Libo Chen. A scholar is included among the top collaborators of Libo Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libo Chen. Libo Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Libo, et al.. (2025). Immune checkpoint inhibitors against thyroid cancer. International Journal of Surgery. 111(10). 7346–7349.
2.
Sun, Di, Gaoda Ju, Lisha Huang, et al.. (2023). Characterizing Genetic Alterations Related to Radioiodine Avidity in Metastatic Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 109(5). 1231–1240. 9 indexed citations
3.
Chen, Yun, et al.. (2023). Second radioiodine treatment hardly benefits TT-DTC patients with radioiodine-negative metastases on initial post-therapeutic whole-body scans. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 67(4). 294–303.
4.
Zhang, Ke, et al.. (2023). Epigenetic Targets and Their Inhibitors in Thyroid Cancer Treatment. Pharmaceuticals. 16(4). 559–559. 6 indexed citations
5.
6.
Li, Lingyu, et al.. (2022). Real-world insights into the efficacy and safety of tyrosine kinase inhibitors against thyroid cancers. Critical Reviews in Oncology/Hematology. 172. 103624–103624. 4 indexed citations
7.
Cheng, Lin, et al.. (2020). Distinguishing Patients With Distant Metastatic Differentiated Thyroid Cancer Who Biochemically Benefit From Next Radioiodine Treatment. Frontiers in Endocrinology. 11. 587315–587315. 9 indexed citations
8.
Jin, Yuchen, et al.. (2019). Mouse models of thyroid cancer: Bridging pathogenesis and novel therapeutics. Cancer Letters. 469. 35–53. 19 indexed citations
9.
Jin, Yuchen, et al.. (2018). Radioiodine refractory differentiated thyroid cancer. Critical Reviews in Oncology/Hematology. 125. 111–120. 62 indexed citations
10.
11.
Wang, Lan, et al.. (2017). Photodegradation of enrofloxacin under different conditions in aqueous systems: kinetics, products and quantum yield.. Fresenius environmental bulletin. 26(7). 4528–4535. 1 indexed citations
12.
Jin, Yuchen, et al.. (2017). Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report. BMC Cancer. 17(1). 735–735. 1 indexed citations
13.
Liu, Min, Maomei Ruan, & Libo Chen. (2014). Update on the molecular diagnosis and targeted therapy of thyroid cancer. Medical Oncology. 31(6). 973–973. 9 indexed citations
14.
Liu, Min, Yan Shen, Maomei Ruan, Ming‐Hua Li, & Libo Chen. (2014). Notable Decrease of Malignant Pleural Effusion After Treatment with Sorafenib in Radioiodine-Refractory Follicular Thyroid Carcinoma. Thyroid. 24(7). 1179–1183. 13 indexed citations
15.
Zhao, Chunlei, Zhong‐Ling Qiu, Libo Chen, Zhibin Yuan, & Quan‐Yong Luo. (2013). Sustained and Diffuse 131I Avid Bone Metastases With Low Thyroglobulin Levels in a Patient With Papillary Thyroid Carcinoma. Clinical Nuclear Medicine. 38(5). 375–377. 6 indexed citations
16.
Shen, Yan, Maomei Ruan, Quan‐Yong Luo, et al.. (2012). Brain Metastasis from Follicular Thyroid Carcinoma: Treatment with Sorafenib. Thyroid. 1273406241–1273406241. 3 indexed citations
17.
Chen, Libo, Yan Shen, Xiaohui Wu, & Quan‐Yong Luo. (2009). Anatomic and metabolic imaging of venous thromboembolism mimicking thyroid carcinoma extension. Journal of Thrombosis and Thrombolysis. 29(3). 358–360. 5 indexed citations
18.
Luo, Quan‐Yong, Qiong Luo, Libo Chen, et al.. (2008). Multiple Subdermal Metastases from Papillary Thyroid Cancer. Thyroid. 18(8). 907–908. 4 indexed citations
19.
Chen, Libo, et al.. (2006). 99mTc-pertechnetate uptake in hepatoma cells due to tissue-specific human sodium iodide symporter gene expression. Nuclear Medicine and Biology. 33(4). 575–580. 23 indexed citations
20.
Zhu, Ruisen, Yongli Yu, Hankui Lu, Quan‐Yong Luo, & Libo Chen. (2005). Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of 131I.. PubMed. 118(5). 425–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans H G Verbeek Breakdown of academic impact, for papers by Carla Vaz Ferreira Breakdown of academic impact, for papers by Libo Chen Breakdown of academic impact, for papers by Patricia Borges de Souza Breakdown of academic impact, for papers by Teresa Ramone Breakdown of academic impact, for papers by Fernando Jerkovich Breakdown of academic impact, for papers by Adriana Gaspar da Rocha Breakdown of academic impact, for papers by Ruichao Zeng Breakdown of academic impact, for papers by Tomasz Trybek Breakdown of academic impact, for papers by Angela Nesca
Rankless by CCL
2026